+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genital Herpes Treatment Market - Global Forecast 2026-2032- Product Image
Genital Herpes Treatment Market - Global Forecast 2026-2032- Product Image
New

Genital Herpes Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6016198
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genital herpes treatment market is evolving rapidly, shaped by clinical innovation, distribution advances, and changing payer expectations. Decision-makers navigating this landscape must balance therapeutic value, operational resilience, and commercial agility to secure competitive advantage.

Market Snapshot: Genital Herpes Treatment Market Growth

The Genital Herpes Treatment Market grew from USD 2.28 billion in 2025 to USD 2.40 billion in 2026. It is expected to continue growing at a CAGR of 5.05%, reaching USD 3.22 billion by 2032. This upward trend indicates a robust market fueled by ongoing therapeutic advancements, expanding patient needs, and dynamic distribution strategies.

Scope & Segmentation

This analysis provides a strategic framework for stakeholders by examining the clinical, operational, and commercial dimensions of the market. Coverage spans:

  • Molecule Types: Analysis of Acyclovir, Famciclovir, Valacyclovir, and differentiation between branded and generic products to inform lifecycle and positioning strategies.
  • Therapy Models: Evaluation of episodic, prophylactic, and suppressive therapy models, with emphasis on their impact on prescribing pathways and support program needs.
  • Distribution Channels: Insights into access points including hospital pharmacy, online pharmacy, and retail pharmacy, with further granularity for private/public sectors, manufacturer-direct, third-party e-retailers, and independent or chain retail outlets.
  • Routes of Administration: Consideration of intravenous, oral (capsules, tablets, liquids), and topical (creams, ointments) formulations relevant to both clinical adoption and patient preference.
  • End Users: Segmentation across homecare (nurse/self-administered), hospitals (private/public), and specialty clinics (dermatology, STD centers) to optimize education and support investments.
  • Indications: Detailed segmentation by asymptomatic shedding, primary infection (adult/pediatric), and recurrence patterns, supporting targeted messaging and care strategies.
  • Regions: Analysis of Americas, Europe, Middle East & Africa, and Asia-Pacific, reflecting diverse payer systems, distribution infrastructures, and care models.
  • Technology Innovations: Overview of advances in antiviral formulations, real-world evidence generation, and the expansion of digital distribution and telehealth platforms.

Key Takeaways for Senior Decision-Makers

  • Advancements in therapeutic options and digital distribution are expanding management pathways and enabling greater patient access.
  • Diverse segmentation—by molecule, therapy, channel, and indication—enables precise targeting for commercial strategies and supportive patient programs.
  • Adapting to local regulatory frameworks and payer demands is essential for successful market entry and sustainable reimbursement models.
  • Integrated distribution models, including telehealth and e-pharmacy, are reshaping how therapies reach patients and align with evolving care preferences.
  • Manufacturers that emphasize formulation innovations and adherence tools can secure stronger clinician confidence and payer alignment.
  • Lifecycle management and evidence-based value claims remain central to optimizing formulary positioning and long-term utilization.

Tariff Impact on Market Operations

Recent tariff policy shifts have affected pharmaceutical procurement and cross-border distribution, impacting cost structures and supply chain resilience. Manufacturers and distributors are revisiting sourcing strategies and contractual terms to ensure supply continuity. Increasing attention to local and regional sourcing, flexible production, and inventory management supports supply security and predictable pricing across provider settings.

In response, procurement teams and wholesalers are applying new contractual protections and, where possible, leveraging near-shoring or regional manufacturing to minimize operational risk. These adaptations are vital for maintaining availability and adapting pricing and contracting strategies in a shifting tariff environment.

Methodology & Data Sources

This report integrates findings from structured expert interviews, validated secondary research, and quantitative distribution analytics. Data sources include clinical experts, procurement professionals, peer-reviewed literature, regulatory communications, and institutional procurement records.

Why This Report Matters

  • Delivers actionable insights for commercial strategists, product development leaders, and clinical operations executives seeking evidence-driven recommendations.
  • Clarifies operational, segmentation, and regional factors affecting supply resilience and market access across diverse payer and provider landscapes.
  • Supports decision-making with transparent methodology, enabling targeted planning and improved alignment between innovation, distribution, and channel execution.

Conclusion

This strategic overview guides executives on balancing clinical, operational, and commercial imperatives to strengthen market position and enhance patient outcomes. Integrated approaches to innovation, supply resilience, and commercial execution are key to maintaining long-term value in the genital herpes treatment market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Genital Herpes Treatment Market, by Molecule
8.1. Acyclovir
8.1.1. Branded
8.1.2. Generic
8.2. Famciclovir
8.2.1. Branded
8.2.2. Generic
8.3. Valacyclovir
8.3.1. Branded
8.3.2. Generic
9. Genital Herpes Treatment Market, by Therapy Model
9.1. Episodic Therapy
9.2. Prophylactic Therapy
9.3. Suppressive Therapy
10. Genital Herpes Treatment Market, by Route Of Administration
10.1. Intravenous
10.1.1. Home Infusion
10.1.2. Hospital Administration
10.2. Oral
10.2.1. Capsules
10.2.2. Liquid
10.2.3. Tablets
10.3. Topical
10.3.1. Cream
10.3.2. Ointment
11. Genital Herpes Treatment Market, by Indication
11.1. Asymptomatic Shedding
11.2. Primary Infection
11.2.1. Adults
11.2.2. Pediatrics
11.3. Recurrent Episodes
11.3.1. First Recurrence
11.3.2. Multiple Recurrences
12. Genital Herpes Treatment Market, by End User
12.1. Homecare Settings
12.1.1. Nurse-administered
12.1.2. Self-administered
12.2. Hospitals
12.2.1. Private
12.2.2. Public
12.3. Specialty Clinics
12.3.1. Dermatology Clinics
12.3.2. STD Clinics
13. Genital Herpes Treatment Market, by Distribution Channel
13.1. Hospital Pharmacy
13.1.1. Private Hospital Pharmacy
13.1.2. Public Hospital Pharmacy
13.2. Online Pharmacy
13.2.1. Manufacturer Direct
13.2.2. Third Party E-retailer
13.3. Retail Pharmacy
13.3.1. Chain Pharmacy
13.3.2. Independent Pharmacy
14. Genital Herpes Treatment Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Genital Herpes Treatment Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Genital Herpes Treatment Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Genital Herpes Treatment Market
18. China Genital Herpes Treatment Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Abcam PLC
19.7. Aurobindo Pharma Limited
19.8. Bio-Rad Laboratories, Inc.
19.9. bioMerieux SA
19.10. Cipla Limited
19.11. DiaSorin S.p.A.
19.12. Dr. Reddy's Laboratories Ltd
19.13. F. Hoffmann-La Roche Ltd.
19.14. GlaxoSmithKline plc
19.15. Hikma Pharmaceuticals plc
19.16. Hologic, Inc.
19.17. Luminex Corporation - A DiaSorin Company
19.18. Lupin Limited
19.19. Merck KGaA
19.20. Meridian Bioscience, Inc. by SD Biosensor and SJL Partners
19.21. Norgen Biotek Corporation
19.22. OneCare Media, LLC
19.23. Qiagen N.V.
19.24. Quidel Corporation
19.25. Rapid STD Testing by RSC Health, PA
19.26. Sandoz International GmbH
19.27. Sun Pharmaceutical Industries Ltd
19.28. Teco Diagnostics
19.29. Teva Pharmaceutical Industries Ltd
19.30. Thermo Fisher Scientific, Inc.
19.31. Viatris Inc
List of Figures
FIGURE 1. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENITAL HERPES TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENITAL HERPES TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA GENITAL HERPES TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY EPISODIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY EPISODIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY EPISODIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PROPHYLACTIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PROPHYLACTIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PROPHYLACTIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SUPPRESSIVE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SUPPRESSIVE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SUPPRESSIVE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOME INFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOME INFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOME INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY OINTMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ASYMPTOMATIC SHEDDING, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ASYMPTOMATIC SHEDDING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ASYMPTOMATIC SHEDDING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FIRST RECURRENCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FIRST RECURRENCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FIRST RECURRENCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MULTIPLE RECURRENCES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MULTIPLE RECURRENCES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MULTIPLE RECURRENCES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY NURSE-ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY NURSE-ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY NURSE-ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SELF-ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SELF-ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY STD CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY STD CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY STD CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MANUFACTURER DIRECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MANUFACTURER DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THIRD PARTY E-RETAILER, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THIRD PARTY E-RETAILER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THIRD PARTY E-RETAILER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 181. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 183. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 184. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 200. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 204. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 205. NORTH AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 221. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 222. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 223. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2032 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2032 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 248. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 250. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 251. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2032 (USD MILLION)
TABLE 252. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 253. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2032 (USD MILLION)
TABLE 254. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 255. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 256. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 257. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 258. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 259. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2032 (USD MILLION)
TABLE 260. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2032 (USD MILLION)
TABLE 261. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 262. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 263. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 264. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 265. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 266. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 267. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 268. EUROPE GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 269. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 271. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 272. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2032 (USD MILLION)
TABLE 273. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 274. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2032 (USD MILLION)
TABLE 275. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 276. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 277. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 278. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 279. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 280. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2032 (USD MILLION)
TABLE 281. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2032 (USD MILLION)
TABLE 282. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 284. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 285. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 286. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 287. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 288. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 289. MIDDLE EAST GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 290. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 292. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 293. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2032 (USD MILLION)
TABLE 294. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2032 (USD MILLION)
TABLE 295. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2032 (USD MILLION)
TABLE 296. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 297. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 298. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 299. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 300. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 301. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2032 (USD MILLION)
TABLE 302. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2032 (USD MILLION)
TABLE 303. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 304. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 305. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 306. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 307. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 308. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 309. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 310. AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 311. ASIA-PACIFIC GENITAL HERPES TREATMENT MARKET SIZE, BY

Companies Mentioned

The key companies profiled in this Genital Herpes Treatment market report include:
  • Abbott Laboratories
  • Abcam PLC
  • Aurobindo Pharma Limited
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cipla Limited
  • DiaSorin S.p.A.
  • Dr. Reddy's Laboratories Ltd
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals plc
  • Hologic, Inc.
  • Luminex Corporation - A DiaSorin Company
  • Lupin Limited
  • Merck KGaA
  • Meridian Bioscience, Inc. by SD Biosensor and SJL Partners
  • Norgen Biotek Corporation
  • OneCare Media, LLC
  • Qiagen N.V.
  • Quidel Corporation
  • Rapid STD Testing by RSC Health, PA
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd
  • Teco Diagnostics
  • Teva Pharmaceutical Industries Ltd
  • Thermo Fisher Scientific, Inc.
  • Viatris Inc

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.4 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.22 Billion
Compound Annual Growth Rate5.0%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Genital Herpes Treatment Drug Market - Global Forecast 2025-2030 - Product Image

Genital Herpes Treatment Drug Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Genital Herpes Market Report 2025 - Product Image

Genital Herpes Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Genital Herpes - Pipeline Insight, 2025 - Product Image

Genital Herpes - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Herpes Simplex Epidemiology Forecast 2025-2034 - Product Image

Herpes Simplex Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Herpes Simplex - Pipeline Insight, 2025 - Product Image

Herpes Simplex - Pipeline Insight, 2025

  • Drug Pipelines
  • 75 Pages
  • Global
From

About the Genital Herpes Drug Market

The Genital Herpes Drug market is a subset of the larger Infectious Diseases Drugs market. Genital Herpes is a sexually transmitted infection caused by the herpes simplex virus (HSV). Treatment for genital herpes includes antiviral medications, which can reduce the severity and duration of symptoms. These drugs can also reduce the risk of transmitting the virus to others. Commonly prescribed medications include acyclovir, valacyclovir, and famciclovir. These drugs are available in both oral and topical forms. The Genital Herpes Drug market is highly competitive, with many companies offering similar products. Major players in the market include GlaxoSmithKline, Novartis, Merck, Pfizer, and Sanofi. Other companies include Mylan, Teva Pharmaceuticals, and Cipla. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.